Antimycobacterial activity of methdilazine (Md), an antimicrobic phenothiazine
- 1 January 1993
- Vol. 101 (1-6) , 449-454
- https://doi.org/10.1111/j.1699-0463.1993.tb00133.x
Abstract
Methdilazine (Md) could inhibit various Mycobacterium spp. at 5-15 micrograms/ml concentrations in vitro as well as in vivo. When Md was tested in combination with streptomycin (Sm), rifampicin (Rf) or methyl-DOPA (m-D), it showed synergistic effects only with respect to methyl-DOPA.Keywords
This publication has 7 references indexed in Scilit:
- Genetic relationships among Mycobacterium leprae, Mycobacterium tuberculosis, and candidate leprosy vaccine strains determined by DNA hybridization: identification of an M. leprae-specific repetitive sequenceInfection and Immunity, 1989
- Antibacterial Effect of Four PhenothiazinesBasic & Clinical Pharmacology & Toxicology, 1987
- Antimykobakterielle β-AminoketoneArchiv der Pharmazie, 1987
- Antibacterial Activity of Ambodryl and BenadrylJournal of Applied Bacteriology, 1976
- ANTAGONISTS OF NUCLEIC ACID DERIVATIVESJournal of Biological Chemistry, 1954
- The Use of Mice in Experimental Chemotherapy of Tuberculosis: I. Rationale and Review of the LiteratureThe Journal of Infectious Diseases, 1948